X-78657184-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_152694.3(RTL3):c.1237G>A(p.Glu413Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000256 in 1,210,789 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 10 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_152694.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000266 AC: 3AN: 112576Hom.: 0 Cov.: 23 AF XY: 0.0000576 AC XY: 2AN XY: 34728
GnomAD3 exomes AF: 0.0000545 AC: 10AN: 183329Hom.: 0 AF XY: 0.0000147 AC XY: 1AN XY: 67801
GnomAD4 exome AF: 0.0000255 AC: 28AN: 1098213Hom.: 0 Cov.: 31 AF XY: 0.0000220 AC XY: 8AN XY: 363579
GnomAD4 genome AF: 0.0000266 AC: 3AN: 112576Hom.: 0 Cov.: 23 AF XY: 0.0000576 AC XY: 2AN XY: 34728
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 21, 2024 | The c.1237G>A (p.E413K) alteration is located in exon 2 (coding exon 1) of the ZCCHC5 gene. This alteration results from a G to A substitution at nucleotide position 1237, causing the glutamic acid (E) at amino acid position 413 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at